Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by Schonfeld Strategic Advisors LLC

Schonfeld Strategic Advisors LLC increased its position in Cardinal Health, Inc. (NYSE:CAH) by 134.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 121,935 shares of the company’s stock after buying an additional 70,020 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in Cardinal Health were worth $14,421,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CAH. Cyrus J. Lawrence LLC acquired a new position in Cardinal Health during the fourth quarter worth approximately $26,000. Promus Capital LLC acquired a new position in Cardinal Health during the fourth quarter worth approximately $30,000. Bellwether Advisors LLC acquired a new position in Cardinal Health during the fourth quarter worth approximately $32,000. Lee Danner & Bass Inc. acquired a new position in Cardinal Health during the fourth quarter worth approximately $35,000. Finally, Kentucky Trust Co purchased a new stake in Cardinal Health during the fourth quarter worth approximately $41,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $139.80 on Wednesday. The company’s fifty day moving average is $131.30 and its 200-day moving average is $124.38. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $140.50. The company has a market capitalization of $33.77 billion, a PE ratio of 26.08, a P/E/G ratio of 1.49 and a beta of 0.61.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were given a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.45%. The ex-dividend date of this dividend was Tuesday, April 1st. Cardinal Health’s dividend payout ratio is presently 37.69%.

Wall Street Analysts Forecast Growth

CAH has been the subject of several research reports. Bank of America boosted their price objective on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. UBS Group boosted their price objective on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Tuesday. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 target price for the company in a research note on Tuesday, January 7th. TD Cowen raised shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and boosted their price objective for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Four investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $142.36.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.